Suzuken Co., Ltd. Provides Dividend Guidance for the Interim of 2022 and Fiscal Year 2022
November 12, 2021 at 01:00 am
Share
Suzuken Co., Ltd. provided dividend guidance for the interim of 2022 and fiscal year 2022. An interim dividend of JPY 36 and an end-of-year dividend of JPY 36 will be paid for the current fiscal year, totaling JPY72.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
